Kuang FL, Fay MP, Ware J, et al.

Title: Long-term clinical outcomes of high-dose mepolizumab treatment for hypereosinophilic syndrome.

Citation: J Allergy Clin Immunol Pract
2018;6:1518–1527.e5.

Country: USA | Indication: HES

This is a GSK-supported study *

http://tago.ca/29751154
* Supported in collaboration with NIH and NIAID
* Supported in collaboration with NIH and NIAID
Scan to access the publication or visit
http://tago.ca/29751154